CAS 2313526-86-0
:Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Se han encontrado 6 productos.
N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide
CAS:Fórmula:C21H19F3N4O4Pureza:99.74%Peso molecular:448.3952Ref: IN-DA01KL03
50mgA consultar100mgA consultar200mgA consultar1mg91,00€2mg177,00€5mg182,00€10mg233,00€250mg591,00€25mg676,00€500mg2.983,00€N-(2-(1H-1,2,4-Triazol-1-Yl)-5-(Trifluoromethoxy)Phenyl)-4-(Cyclopropylmethoxy)-3-Methoxybenzamide
CAS:N-(2-(1H-1,2,4-Triazol-1-Yl)-5-(Trifluoromethoxy)Phenyl)-4-(Cyclopropylmethoxy)-3-MethoxybenzamideFórmula:C21H19F3N4O4Pureza:98%Peso molecular:448.4VU6012962
CAS:N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamideFórmula:C21H19F3N4O4Pureza:98%Peso molecular:448.4N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide
CAS:N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide is a modulator of metabotropic glutamate receptors. It has been shown to be orally bioavailable and to have an effect on the spinal cord. This drug is effective in doses ranging from 1 mg/kg to 10 mg/kg. N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide is still in preclinical stages and has not been tested on humans yet.Fórmula:C21H19F3N4O4Pureza:Min. 95%Peso molecular:448.4 g/molVU6012962
CAS:VU6012962 is an orally bioavailable negative allosteric modulator of CNS-penetrant metabotropic glutamate receptor 7(mGlu7; IC50: 347 nM).Fórmula:C21H19F3N4O4Pureza:99.61% - 99.74%Forma y color:SolidPeso molecular:448.4
